Literature DB >> 6193378

Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia.

M E Stewart, J T Douglas, G D Lowe, C R Prentice, C D Forbes.   

Abstract

Plasma levels of beta-thromboglobulin (BTG) and fibrinopeptide A (FPA), markers of platelet alpha-granule release and thrombin generation respectively, were measured in 27 subjects with transient cerebral ischaemic attacks (TIA), 43 age-matched controls, and 32 young controls. BTG and FPA were both higher in elderly controls than in young controls. BTG was higher in TIA subjects than in age-matched controls and higher in the 12 TIA subjects who had further vascular events in the next year than in those who had no further events. FPA was not significantly associated with TIA or with further events. These results support a relationship between platelet activation and TIA and suggest that BTG levels indicate a group at higher risk of further vascular events.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193378     DOI: 10.1016/s0140-6736(83)90511-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Platelet aggregation in transient global amnesia.

Authors:  J Matias-Guiu; M Pico; I Bonaventura; R Martin; J Monasterio
Journal:  Ital J Neurol Sci       Date:  1989-04

2.  Beta-thromboglobulin in cerebral infarction.

Authors:  E Woo; C Y Huang; V Chan; Y W Chan; Y L Yu; T K Chan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

Review 3.  Anticoagulant drugs in the elderly: valuable in selected patients.

Authors:  G D Lowe
Journal:  BMJ       Date:  1988-11-12

4.  Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients.

Authors:  C P Lau; H F Tse; G Cheng
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

5.  The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.

Authors:  J De Cree; J Leempoels; B Demoen; V Roels; H Verhaegen
Journal:  Agents Actions       Date:  1985-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.